Page 112 - CPG - Clinical Practice Guidelines - Management of Cancer Pain
P. 112
Management of Cancer Pain (Second Edition)
ropivacaine
ropivacaine
&*$ FRUUHFWHG JHVWDWLRQDO DJH ,5 LPPHGLDWH UHOHDVH ,9 LQWUDYHQRXV /$ ORFDO
LQ¿OWUDWLRQ 1% QHZERUQ 26$ REVWUXFWLYH VOHHS DSQRHD 6& VXEFXWDQHRXV 65
slow release; PCA: patient-controlled analgesia; RA: regional anaesthesia; H: hour;
0D[ PD[LPXP /' ORDGLQJ GRVH 0' PDLQWHQDQFH GRVH ,%: LGHDO ERG\ ZHLJKW
ON: on night
)RU 2EHVH &KLOGUHQ UHFRPPHQGHG DGMXVWPHQWV IRU GUXJ GRVLQJ:
Opioids: Ideal Body weight (IBW);
3DUDFHWDPRO DQG 16$,' $GMXVWHG %RG\ :HLJKW ,%: [ $FWXDO %: ,%:
$GDSWHG 0LQLVWU\ RI +HDOWK 0DOD\VLD 3DHGLDWULF 3DLQ 0DQDJHPHQW *XLGHOLQHV
2023. Putrajaya: MoH; 2023.
94
e-cpg inside text-Cancer pain-25/5/24.indd 94 09/08/2024 12:09 AM
